Assessing Treatment Benefit in Immuno-oncology
Adaptations to tumor response and progression criteria for immune therapies. Abstract Immuno-oncology is a buoyant field of research, with recently…
Discover the news of an experienced Contract Research Organization specialized in Biostatistics and eClinical services to optimize your clinical trials.
Adaptations to tumor response and progression criteria for immune therapies. Abstract Immuno-oncology is a buoyant field of research, with recently…
Testing novel agents in gastrointestinal cancer requires continued attention to statistical issues related to endpoints. Purpose of Review: Clinical-trial design,…
June 14, 2020 — June 18, 2020
The DIA 2020 Global Annual Meeting will still go on, in the digital realm! IDDI will have a virtual booth –…
June 25, 2020
IDDI Partner at the Clinical Operations online strategy meeting Join IDDI at Proventa Clinical Operations online strategy meeting where clinical…
June 30, 2020
IDDI Partner at the Proventa Online Oncology Strategy Meeting Join IDDI and pharma, biotech and investors from across Europe at…
June 8, 2020 — June 12, 2020
San Diego, CA
Meet IDDI at Bio Digital The BIO International Convention will transition to a new, virtual event format, BIO US Digital….
May 2, 2020 — May 10, 2020
IDDI joins the Covid-19km challenge for solidarity with those severely impacted by the current crisis. The Covid 19km challenge consists…
FDA and EMA recently each issued guidance on the management of clinical trials during the COVID-19 pandemic. Read FDA Guidance…
As a result of the outbreak of COVID-19, IDDI has implemented strict measures to preserve the health and safety of our…
NEWSLETTER APRIL 2020 CLINICAL TRIAL NEWS ABOUT US BIOSTATISTICAL SERVICES eCLINICAL SERVICES CONTACT US IDDI and COVID-19 – A…